MEETINGS - The Clash over Diagnostic and Screening Technology (US) October 1997:
This article was originally published in Clinica
A conference on The Clash over Diagnostic and Screening Technology: Balancing Consumer Needs, Payer and Provider Constraints, and the Public Good will take place in Philadelphia on October 20-21. Issues to be addressed at the conference include the art and science of bedside diagnosis; how the FDA interprets safety and effectiveness for screening and diagnostic technologies; and the adoption and diffusion of cost-effective testing. Contact the ECRI for more information. Tel: +1 610 825 6000. Fax: +1 610 834 1275.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.